| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $64.4M | +34.0% |
| Cost of Revenue | $7.7M | +48.4% |
| Gross Profit | $56.7M | +32.2% |
| R&D Expense | $52.9M | +11.0% |
| SG&A Expense | $82.8M | -5.4% |
| Operating Income | -$79.0M | +14.4% |
| Pre-tax Income | -$108.0M | +1.2% |
| Income Tax | $1.8M | +21.1% |
| Net Income | -$109.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.4M | +24.9% |
| Accounts Receivable | $12.7M | +8.4% |
| Inventory | $4.3M | -10.5% |
| Current Assets | $128.9M | +12.7% |
| Total Assets | $135.6M | +13.3% |
| Current Liabilities | $23.9M | +6.9% |
| Long-term Debt | $97.5M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$87.6M | -3.1% |
| Capital Expenditures | $254K | -66.2% |
| Investing Cash Flow | $1.1M | -73.9% |
| Financing Cash Flow | $97.1M | +34.3% |
| Free Cash Flow | -$87.8M | -2.5% |
| +0.9% |
| EPS (Basic) | -$4.81 | +3.0% |
| Total Liabilities |
| $225.0M |
| +102.1% |
| Stockholders' Equity | -$89.4M | -1162.2% |